TNNT3
Troponin T, fast skeletal muscle
Also known as: AMCD2B, DA2B, DKFZp779M2348, FSSV, TNNT3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P45378
- Gene
- TNNT3
- Ensembl
- ENSG00000130595
- Chromosome
- 11
- Canonical length
- 269 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
The binding of Ca(2+) to the trimeric troponin complex initiates the process of muscle contraction. Increased Ca(2+) concentrations produce a conformational change in the troponin complex that is transmitted to tropomyosin dimers situated along actin filaments. The altered conformation permits increased interaction between a myosin head and an actin filament which, ultimately, produces a muscle contraction. The troponin complex has protein subunits C, I, and T. Subunit C binds Ca(2+) and subunit I binds to actin and inhibits actin-myosin interaction. Subunit T binds the troponin complex to the tropomyosin complex and is also required for Ca(2+)-mediated activation of actomyosin ATPase activity. There are 3 different troponin T genes that encode tissue-specific isoforms of subunit T for fast skeletal-, slow skeletal-, and cardiac-muscle. This gene encodes fast skeletal troponin T protein; also known as troponin T type 3. Alternative splicing results in multiple transcript variants encoding additional distinct troponin T type 3 isoforms. A developmentally regulated switch between fetal/neonatal and adult troponin T type 3 isoforms occurs. Additional splice variants have been described but their biological validity has not been established. Mutations in this gene may cause distal arthrogryposis multiplex congenita type 2B (DA2B). [provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
269 residues, UniProt reviewed canonical sequence.
>P45378|TNNT3
1 MSDEEVEQVE EQYEEEEEAQ EEAAEVHEEV HEPEEVQEDT AEEDAEEEKP RPKLTAPKIP
61 EGEKVDFDDI QKKRQNKDLM ELQALIDSHF EARKKEEEEL VALKERIEKR RAERAEQQRI
121 RAEKERERQN RLAEEKARRE EEDAKRRAED DLKKKKALSS MGANYSSYLA KADQKRGKKQ
181 TAREMKKKIL AERRKPLNID HLGEDKLRDK AKELWETLHQ LEIDKFEFGE KLKRQKYDIT
241 TLRSRIDQAQ KHSKKAGTPA KGKVGGRWKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TNNT3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 13,033 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 13,033 nTPM
- tongue: 4,207 nTPM
- salivary gland: 211 nTPM
- heart muscle: 191 nTPM
- esophagus: 59 nTPM
- placenta: 39 nTPM
Single-cell type
- thymic myoid cells: 4,499 nCPM
- peritubular myoid cells: 65 nCPM
- ocular epithelial cells: 55 nCPM
- leydig cells: 49 nCPM
- myonuclei: 49 nCPM
- urothelial cells: 43 nCPM
Immune cell
- basophil: 5.3 nTPM
- plasmacytoid DC: 0.3 nTPM
- neutrophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebral cortex: 0.5 nTPM
- white matter: 0.2 nTPM
- amygdala: 0.1 nTPM
- basal ganglia: 0.1 nTPM
- cerebellum: 0.1 nTPM
- hippocampal formation: 0.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TNNT3.
Disease | AllUniProt
Conditions TNNT3 is implicated in, by any mechanism.
- Arthrogryposis, distal, 2B2 (DA2B2) MIM:618435
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 312 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Arthrogryposis, distal, type 2B2
- Sheldon-Hall syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.98
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.46
- DepMap mean gene effect
- 0.16
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- regulation of ATP-dependent activity
- regulation of striated muscle contraction
- sarcomere organization
- skeletal muscle contraction
- positive regulation of calcium-dependent ATPase activity
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TNNT3 as an antibody target. Whether an autoantibody or antibody against TNNT3 could matter depends on whether native TNNT3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TNNT3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TNNT3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...